Literature DB >> 24758556

Unenhanced MR angiography of the foot: initial experience of using flow-sensitive dephasing-prepared steady-state free precession in patients with diabetes.

Xin Liu1, Zhaoyang Fan, Na Zhang, Qi Yang, Fei Feng, Pengcheng Liu, Hairong Zheng, Debiao Li.   

Abstract

PURPOSE: To assess image quality and diagnostic performance of unenhanced magnetic resonance (MR) angiography with use of flow-sensitive dephasing (FSD)-prepared steady-state free precession (SSFP) of the foot arteries in patients with diabetes.
MATERIALS AND METHODS: This prospective study was approved by institutional review board. Informed consent was obtained from all subjects. Thirty-two healthy volunteers and 38 diabetic patients who had been scheduled for lower-extremity contrast material-enhanced MR angiography were recruited to undergo unenhanced MR angiography with a 1.5-T MR unit. Image quality and diagnostic accuracy of unenhanced MR angiography in the detection of significant arterial stenosis (≥50%) were assessed by two independent reviewers. Contrast-enhanced MR angiography was used as the reference standard. The difference in the percentage of diagnostic arterial segments at unenhanced MR angiography between healthy volunteers and diabetic patients was evaluated with the McNemar test and generalized estimating equation for correlated data. Signal-to-noise ratio (SNR) and artery-to-muscle contrast-to-noise ratio (CNR) of pedal arteries were measured and compared between the two MR angiography techniques by using the paired t test.
RESULTS: All subjects successfully underwent unenhanced MR angiography of the foot. Unenhanced MR angiography yielded a high percentage of diagnostic arterial segments in both healthy volunteers (303 of 320 segments, 95%) and patients (341 of 370 segments, 92%), and there was no difference in the percentage between the two populations (P = .195). In patients, the average SNR and CNR at unenhanced MR angiography were higher than those at contrast-enhanced MR angiography (SNR: 90.7 ± 38.1 vs 81.7 ± 34.7, respectively, P = .023; CNR: 85.2 ± 33.2 vs 76.6 ± 33.5, respectively, P = .013). The average sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of unenhanced MR angiography were 88% (35 of 40 segments), 93% (107 of 115 segments), 81% (35 of 43 segments), 96% (107 of 112 segments), and 92% (142 of 155 segments), respectively. Interobserver agreement between the two readers for diagnostic accuracy was good (κ = 0.83).
CONCLUSION: Unenhanced MR angiography with use of FSD-prepared SSFP allows clear depiction of the foot arterial tree and accurate detection of significant arterial stenosis. The technique has the potential to be a safe and reliable screening tool for the assessment of foot arteries in diabetic patients without the use of gadolinium-based contrast material.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24758556      PMCID: PMC4154940          DOI: 10.1148/radiol.14132284

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  34 in total

Review 1.  A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease.

Authors:  R J Hinchliffe; G Andros; J Apelqvist; K Bakker; S Friederichs; S Fiedrichs; J Lammer; M Lepantalo; J L Mills; J Reekers; C P Shearman; G Valk; R E Zierler; N C Schaper
Journal:  Diabetes Metab Res Rev       Date:  2012-02       Impact factor: 4.876

2.  Noise measurement and estimation in MR imaging experiments.

Authors:  Johannes T Heverhagen
Journal:  Radiology       Date:  2007-12       Impact factor: 11.105

3.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

Authors:  G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

Review 4.  High temporal and spatial resolution 3D time-resolved contrast-enhanced magnetic resonance angiography of the hands and feet.

Authors:  Clifton R Haider; Stephen J Riederer; Eric A Borisch; James F Glockner; Roger C Grimm; Thomas C Hulshizer; Thanila A Macedo; Petrice M Mostardi; Phillip J Rossman; Terri J Vrtiska; Phillip M Young
Journal:  J Magn Reson Imaging       Date:  2011-07       Impact factor: 4.813

5.  Peripheral vascular disease: comparison of continuous MR angiography and conventional MR angiography--pilot study.

Authors:  Florian M Vogt; Michael O Zenge; Mark E Ladd; Christoph U Herborn; Katja Brauck; Wolfgang Luboldt; Jörg Barkhausen; Harald H Quick
Journal:  Radiology       Date:  2007-02-28       Impact factor: 11.105

6.  Time-resolved MR angiography of the legs at 3 T using a low dose of gadolinium: initial experience and contrast dynamics.

Authors:  Gurpreet Singh Sandhu; Rod P Rezaee; John Jesberger; Katherine Wright; Mark A Griswold; Vikas Gulani
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

7.  Renal artery assessment with nonenhanced steady-state free precession versus contrast-enhanced MR angiography.

Authors:  Rolf Wyttenbach; Antonio Braghetti; Michael Wyss; Mario Alerci; Lukas Briner; Paolo Santini; Luca Cozzi; Marcello Di Valentino; Marcus Katoh; Claudio Marone; Peter Vock; Augusto Gallino
Journal:  Radiology       Date:  2007-08-23       Impact factor: 11.105

8.  3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP.

Authors:  Zhaoyang Fan; John Sheehan; Xiaoming Bi; Xin Liu; James Carr; Debiao Li
Journal:  Magn Reson Med       Date:  2009-12       Impact factor: 4.668

9.  Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.

Authors:  Matthias Voth; Stefan Haneder; Kurt Huck; Alexandra Gutfleisch; Stefan O Schönberg; Henrik J Michaely
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

10.  A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases.

Authors:  Frank B Pomposelli; Nikhil Kansal; Alan D Hamdan; Alana Belfield; Malachi Sheahan; David R Campbell; John J Skillman; Frank W Logerfo
Journal:  J Vasc Surg       Date:  2003-02       Impact factor: 4.268

View more
  5 in total

Review 1.  Noncontrast MR angiography: An update.

Authors:  Robert R Edelman; Ioannis Koktzoglou
Journal:  J Magn Reson Imaging       Date:  2018-12-19       Impact factor: 4.813

2.  DANTE-prepared three-dimensional FLASH: A fast isotropic-resolution MR approach to morphological evaluation of the peripheral arterial wall at 3 Tesla.

Authors:  Guoxi Xie; Nan Zhang; Yibin Xie; Christopher Nguyen; Zixin Deng; Xiaoming Bi; Zhanming Fan; Xin Liu; Debiao Li; Zhaoyang Fan
Journal:  J Magn Reson Imaging       Date:  2015-07-02       Impact factor: 4.813

3.  Noncontrast MR angiography (MRA) of infragenual arteries using flow-sensitive dephasing (FSD)-prepared steady-state free precession (SSFP) at 3.0 Tesla: Comparison with contrast-enhanced MRA.

Authors:  Nan Zhang; Zhaoyang Fan; Nan Luo; Xiaoming Bi; Yike Zhao; Jing An; Jiayi Liu; Zhong Chen; Zhanming Fan; Debiao Li
Journal:  J Magn Reson Imaging       Date:  2015-07-16       Impact factor: 4.813

4.  Image Quality and Stenosis Assessment of Non-Contrast-Enhanced 3-T Magnetic Resonance Angiography in Patients with Peripheral Artery Disease Compared with Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography.

Authors:  Jiayi Liu; Nan Zhang; Zhaoyang Fan; Nan Luo; Yike Zhao; Xiaoming Bi; Jing An; Zhong Chen; Dongting Liu; Zhaoying Wen; Zhanming Fan; Debiao Li
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

5.  Novel, non-gadolinium-enhanced magnetic resonance imaging technique of pedal artery aneurysms.

Authors:  J Devin B Watson; Beatrice Grasu; Rajiv Menon; Raymond Pensy; Robert S Crawford; Taehoon Shin
Journal:  J Vasc Surg Cases Innov Tech       Date:  2017-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.